According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
Eidos Therapeutics CEO bought 1,000,000 shares
Eidos Therapeutics Inc. (EIDX, Financial) CEO and 10% Owner Neil Kumar bought 1 million shares on June 22 at a price of $17.00. The price of the stock has increased by 28.82% since.
Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. Its shares traded at $21.90 as of June 22.
On June 22, the company announced the closing of its initial public offering of 7,187,500 shares of common stock at a public offering price of $17.00 per share.
Director Rajeev M. Shah bought 1,058,824 shares on June 22 at a price of $17. The price of the stock has increased by 28.82% since.
Director and 10% Owner Ali J. Satvat bought 1,000,000 shares on June 22 at a price of $17. The price of the stock has increased by 28.82% since.
10% Owner Capital Healthcare Fund LP RA bought 1,058,824 shares on June 22 at a price of $17. The price of the stock has increased by 28.82% since.
Palo Alto Networks CEO bought 62,395 shares
Palo Alto Networks Inc. (PANW, Financial) CEO Nikesh Arora bought 62,395 shares on June 15 at a price of $214.44. The price of the stock has decreased by 3.19% since.
Palo Alto Networks develops and sells network and endpoint cybersecurity solutions to enterprise customers. The company has a market cap of $19.28 billion. Its shares traded at $207.59 as of June 22.
Non-GAAP net income for the fiscal third quarter of 2018 was $95.1 million compared to $57.1 million for the fiscal third quarter 2017.
Arora also bought 33,255 shares on June 8 at a price of $199.2. The price of the stock has increased by 4.21% since.
Executive Vice President and Chief Financial Officer Kathleen Bonanno sold 5,818 shares on June 11 at a price of $199.61. The price of the stock has increased by 4% since.
Executive Vice President and Chief Technology Officer Nir Zuk sold 30,000 shares on June 18 at a price of $212.85. The price of the stock has decreased by 2.47% since.
Director Stanley J. Meresman sold 1,979 shares on June 13 at a price of $212.17. The price of the stock has decreased by 2.16% since.
Executive Vice President and Chief Product Officer Lee Klarich sold 8,894 shares on June 12 at a price of $202.08. The price of the stock has increased by 2.73% since.
Director Mark D. Mclaughlin sold 40,000 shares on June 12 at a price of $202.33. The price of the stock has increased by 2.6% since.
Executive Vice President and Chief Marketing Officer Rene Bonvanie sold 13,503 shares on June 11 at a price of $199.03. The price of the stock has increased by 4.3% since.
Arthur J. Gallagher & Co. CEO bought 9,090 shares
Arthur J. Gallagher & Co. (AJG, Financial) President and CEO J. Patrick Gallagher Jr. bought 9,090 shares on June 19 at a price of $66.11. The price of the stock has increased by 0.95% since.
Arthur J. Gallagher & Co. is engaged in providing insurance brokerage and consulting services and third-party claims settlement and administration services to both domestic and international entities. The company has a market cap of $12.16 billion. Its shares traded at $66.74 with a price-earnings ratio of 24.12 as of June 22.
Net earnings for the first quarter of 2018 was $242.0 million compared to $286.0 million for the prior-year period.
Marriott Vacations Worldwide CEO bought 4,058 shares
Marriott Vacations Worldwide Corp. (VAC, Financial) President and CEO Stephen P. Weisz bought 4,058 shares on June 15 at a price of $117.86. The price of the stock has increased by 0.1% since.
Marriott Vacations Worldwide is an owner of holiday resorts primarily in the United States. Its portfolio of properties includes Marriott Vacation Club, Grand Residencies and The Ritz-Carlton Destination Club. The company has a market cap of $3.13 billion. Its shares traded at $117.98 with a price-earnings ratio of 13.85 as of June 22.
Net income for the first quarter of 2018 was $36 million compared to net income of $28 million in the first quarter of 2017.
OPKO Health CEO bought 74,299 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman, and 10% Owner Phillip Frost bought 74,299 shares during the past week at an average price of $4.43.
OPKO Health is a diversified health care company that seeks to establish industry-leading positions in large, rapidly growing markets. The company has a market cap of $2.56 billion. Its shares traded at $4.57 as of June 22.
Net loss for the first quarter of 2018 was $43.1 million compared to a net loss of $34.5 million for the comparable period of 2017.
Frost bought 10,000 shares on June 11 at a price of $4.22; 10,000 shares on June 15 at a price of $4.42; 14,299 shares on June 18 at a price of $4.34; 20,000 shares on June 19 at a price of $4.32; and 30,000 shares on June 21 at a price of $4.54. The price of the stock has increased by 0.66% since.
Director Robert Scott Fishel bought 2,500 shares on May 29 at a price of $3.73. The price of the stock has increased by 22.52% since.
For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
